Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide

被引：32
|
作者：
Hamaguchi, T [1 ]
Hirose, T [1 ]
Asakawa, H [1 ]
Itoh, Y [1 ]
Kamado, K [1 ]
Tokunaga, K [1 ]
Tomita, K [1 ]
Masuda, H [1 ]
Watanabe, N [1 ]
Namba, M [1 ]
机构：
[1] Hyogo Med Univ, Dept Internal Med, Div Diabet & Metab, Nishinomiya, Hyogo 6638501, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2004年 / 66卷
关键词：
third-generation sulfonylurea; extrapancreatic effects; insulin resistance; metabolic syndrome;
D O I：
10.1016/j.diabres.2003.12.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multicentric study was conducted to evaluate the efficacy of glimepiride in the oral hypoglycemic agents therapy of type 2 diabetic patients treated with glibenclamide so far, and to claim an adequate use of this new generation sulfonylurea. In 66 diabetic outpatients, glibenclamide was switched to glimepiride. After 6 months' therapy, a significant reduction in fasting plasma IRI was observed in relatively hyperinsulinemic patients. In addition, weight reduction was achieved in patients with insulin resistance during this study. These findings suggest that glimepiride improves insulin resistance in hyperinsulinemic patients treated with glibenclamide. Also, glimepiride is favored especially for overweight, insulin-resistant patients inadequately controlled by glibenclamide. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：S129 / S132
页数：4
相关论文
共 50 条
  • [1] Lower incidence of severe hypoglycaemia in type 2 diabetic patients treated with glimepiride versus glibenclamide
    Holstein, A
    Plaschke, A
    Egberts, EH
    DIABETOLOGIA, 2000, 43 : A40 - A40
  • [2] Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients
    Katakami, Naoto
    Kaneto, Hideaki
    Matsuhisa, Munehide
    Shimomura, Iichiro
    Yamasaki, Yoshimitsu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 92 (01) : E20 - E22
  • [3] The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide
    MassiBenedetti, M
    Herz, M
    Pfeiffer, C
    HORMONE AND METABOLIC RESEARCH, 1996, 28 (09) : 451 - 455
  • [4] Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients
    Abbink, EJ
    Pickkers, P
    van Rosendaal, AJ
    Lutterman, JA
    Tack, CJ
    Russel, FGM
    Smits, P
    DIABETIC MEDICINE, 2002, 19 (02) : 136 - 143
  • [5] Ischemic reaction in diabetic patients with coronary heart disease treated with glibenclamide or glimepiride
    Hücking, K
    Klamann, A
    Jonas, M
    Müller-Lung, U
    Heuser, L
    Launhardt, V
    Ritzel, R
    Schmiegel, WH
    Nauck, MA
    DIABETOLOGIA, 1999, 42 : A280 - A280
  • [6] Lack of Therapeutic Efficacy on Type 2 Diabetic Patients Treated with Glibenclamide and Metformin in Mexico City
    Ramos-Coss, Mauricio
    Rodriguez-Rivera, Nidia
    Molina-Guarneros, Juan A.
    Castillo-Najera, Fernando
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 488 - 489
  • [7] Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide
    Holstein, A
    Plaschke, A
    Egberts, EH
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2001, 17 (06) : 467 - 473
  • [8] Efficacy of glimepiride in Japanese type 2 diabetic subjects
    Inukai, K
    Watanabe, M
    Nakashima, Y
    Sawa, T
    Takata, N
    Tanaka, M
    Kashiwabara, H
    Yokota, K
    Suzuki, M
    Kurihara, S
    Awata, T
    Katayama, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (03) : 250 - 257
  • [9] Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus
    Gonzalez-Ortiz, Manuel
    Guerrero-Romero, Jesus F.
    Violante-Ortiz, Rafael
    Wacher-Rodarte, Niels
    Martinez-Abundis, Esperanza
    Aguilar-Salinas, Carlos
    Islas-Andrade, Sergio
    Arechavaleta-Granell, Rosario
    Gonzalez-Canudas, Jorge
    Rodriguez-Moran, Martha
    Zavala-Suarez, Etelvina
    Ramos-Zavala, Maria G.
    Metha, Roopa
    Revilla-Monsalve, Cristina
    Beltran-Jaramillo, Teresita J.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (06) : 376 - 379
  • [10] Efficacy of troglitazone in type 2 diabetic patients adequately controled with glibenclamide.
    Katoh, S
    Tsuruoka, N
    Hata, S
    Matsushima, M
    Ikemoto, S
    Inoue, Y
    Yokoyama, J
    Tajima, N
    DIABETOLOGIA, 1999, 42 : A229 - A229
12345